Market Research Report
Deuterated Drugs Formulations Therapeutics Markets Strategies
|Published by||Greystone Research Associates||Product code||539022|
Delivery time: 1-2 business days
|Deuterated Drugs Formulations Therapeutics Markets Strategies|
|Published: August 7, 2017||Content info:||
Deuterated Drugs: Products, Pipelines, Strategies, Therapeutics and Markets is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug formulation developers, product designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for drugs that incorporate deuterium into the chemical structure of APIs to modify drug properties in vivo. Provider organization business managers, healthcare administrators and investors will also benefit from this study.